Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Small Cell Lung Cancer, SCLC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT03048136
What this trial is testing

A Safety Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb
Not applicableEnded earlyNCT02551211
What this trial is testing

Association Between Circulating Immune Cells and the Tumor Immune Contexture in Resectable Non-small Cell Lung Cancer

Who this might be right for
Resectable Non-small Lung Cancer
University Hospital, Rouen 22
Testing effectiveness (Phase 2)Study completedNCT03562871
What this trial is testing

IO102 With Pembrolizumab, With or Without Chemotherapy, as First-line Treatment of Metastatic NSCLC

Who this might be right for
NSCLC
IO Biotech 109
Testing effectiveness (Phase 2)Study completedNCT01160744
What this trial is testing

Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Eli Lilly and Company 280
Not applicableNo Longer AvailableNCT01947608
What this trial is testing

Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Ended earlyNCT00321308
What this trial is testing

Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell Lung
Pfizer 36
Testing effectiveness (Phase 2)Study completedNCT01844791
What this trial is testing

An Exploratory Study of OCZ103-OS in Combination With Standard of Care in Stage IV Non-Small Cell Lung Cancer (NSCLC) Patients

Who this might be right for
Non-small Cell Lung Cancer
Oncozyme Pharma Inc. 25
Very early researchLooking for participantsNCT06639191
What this trial is testing

[177Lu]Lu-AKIR001 First-in-human Study

Who this might be right for
Thyroid Gland Anaplastic CarcinomaPoorly Differentiated Thyroid CarcinomaCancer Head and Neck+3 more
Karolinska University Hospital 15
Testing effectiveness (Phase 2)Study completedNCT00410189
What this trial is testing

BATTLE Program: ZD6474 in Previously Treated Subjects With NSCLC

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 54
Testing effectiveness (Phase 2)Looking for participantsNCT04585750
What this trial is testing

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Who this might be right for
Advanced Solid TumorAdvanced Malignant NeoplasmMetastatic Cancer+27 more
PMV Pharmaceuticals, Inc 300
Large-scale testing (Phase 3)Study completedNCT00148291
What this trial is testing

Phase III Study of Docetaxel Vs Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
West Japan Thoracic Oncology Group 180
Early research (Phase 1)Ended earlyNCT05573035
What this trial is testing

Investigate LYL845 in Adults With Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerColorectal Cancer
Lyell Immunopharma, Inc. 39
Testing effectiveness (Phase 2)Looking for participantsNCT06582940
What this trial is testing

Elimination of PTV Margins Based on MRI-guided Adaptive Stereotactic Radiotherapy for Non-small Cell Lung Cancer With Brain Metastasis

Who this might be right for
MRI-guided Adaptive RadiotherapyNon-small Cell Lung CancerBrain Metastasis
Sun Yat-sen University 168
Testing effectiveness (Phase 2)Study completedNCT00079040
What this trial is testing

Cisplatin, Etoposide, and Bevacizumab in Treating Patients With Previously Untreated Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung Cancer
National Cancer Institute (NCI) 65
Early research (Phase 1)Looking for participantsNCT07107490
What this trial is testing

A PHASE I STUDY OF ALPS12 IN PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Chugai Pharmaceutical 122
Large-scale testing (Phase 3)UnknownNCT02011997
What this trial is testing

Comparison of cVATS Segmentectomy Versus Lobectomy for Lung Adenocarcinoma in Situ and With Microinvasion

Who this might be right for
Non-small Cell Lung Cancer Stage ILung Adenocarcinoma
The First Affiliated Hospital of Guangzhou Medical University 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT03999710
What this trial is testing

Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung CancerLung CancerNsclc+2 more
Memorial Sloan Kettering Cancer Center 61
Testing effectiveness (Phase 2)Study completedNCT00951613
What this trial is testing

NK012 in Patients With Relapsed Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Nippon Kayaku Co., Ltd. 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT02498613
What this trial is testing

Cediranib in Combination With Olaparib in Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+23 more
National Cancer Institute (NCI) 122
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06537297
What this trial is testing

Intrathecal Pemetrexed Combined With High-dose Furmonertinib and Beva for EGFR-m NSCLC With Leptomeningeal Metastases

Who this might be right for
Non-small Cell Lung Cancer
Hunan Province Tumor Hospital 30
Next Page